NETO2 and prostate cancer: The highest correlation coefficients were observed between NETO2 expression and pathological stage for breast cancer (rs = 0.15) and prostate cancer (rs = 0.25), tumor differentiation for prostate cancer (rs = −0.16), and BRAF mutation status (rs = 0.18) for colorectal cancer.